Mifepristone

BreastfeedingPediatric

Contra-indicated in pregnancy, with concurrent use of simvastatin or lovastatin and CYP3A substrates with narrow therapeutic range or long-term corticosteroid use, and in women with a history of unexplained vaginal bleeding or with endometrial hyperplasia with atypia or endometrial carcinoma.

TERMINATION OF PREGNANCY

See full prescribing information for complete boxed warning.

Our database has 47 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
GENITOURINARY.
HEMATOLOGIC.
NEUROMUSCULAR/SKELETAL.
RESPIRATORY.
OTHER.


Page last updated 11/21/2018

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top